The University of Cambridge-aligned healthcare and life sciences accelerator has added Novartis as a strategic partner.
Start Codon, a healthcare and life sciences accelerator backed by Cambridge Innovation Capital (CIC), the venture capital investor focused on the Cambridge, UK ecosystem, has raised £15m ($20m) for its first venture capital fund.
The raise was announced yesterday and represents a final close. In addition to CIC, limited partners include pharmaceutical firm Novartis, which will also collaborate with Start Codon strategically.
Start Codon recently enrolled its second cohort on the way to its target of sustaining 50…
